ONCOZ — Oncozenge AB Cashflow Statement
0.000.00%
- SEK70.82m
- SEK74.61m
- SEK2.66m
Annual cashflow statement for Oncozenge AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PRESS | ARS | ARS | ARS | PRESS |
| Standards: | — | SAS | SAS | SAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -4.89 | -43.6 | -15.9 | -8.69 | -15.8 |
| Non-Cash Items | 0 | 23.5 | 0 | -0.003 | -0.153 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.127 | -1.97 | -1.18 | -0.076 | 2.88 |
| Change in Accounts Receivable | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -4.77 | -22.1 | -17.1 | -8.76 | -13.1 |
| Other Investing Cash Flow Items | -5.36 | 0 | 0.57 | 0 | — |
| Change in Net Intangibles | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -5.36 | 0 | 0.57 | 0 | — |
| Financing Cash Flow Items | -8.74 | 0 | — | — | -0.635 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 51.3 | 0 | — | — | 12.9 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 41.2 | -22.1 | -16.5 | -8.76 | -0.149 |